|
Diabetes, Vol 48, Issue 3 616-622, Copyright © 1999 by American Diabetes Association
Fatty acids modulate the composition of extracellular matrix in cultured human arterial smooth muscle cells by altering the expression of genes for proteoglycan core proteins
U Olsson, G Bondjers and G Camejo
Wallenberg Laboratory for Cardiovascular Research, Faculty of Medicine, University of Gothenburg, Sweden. urban.olsson@wlab.wall.gu.se
In diabetes-associated microangiopathies and atherosclerosis, there are
alterations of the extracellular matrix (ECM) in the intima of small and
large arteries. High levels of circulating nonesterified fatty acids
(NEFAs) are present in insulin resistance and type 2 diabetes. High
concentrations of NEFAs might alter the basement membrane composition of
endothelial cells. In arteries, smooth muscle cells (SMCs) are the major
producers of proteoglycans and glycoproteins in the intima, and this is the
site of lipoprotein deposition and modification, key events in
atherogenesis. We found that exposure of human arterial SMCs to 100-300
micromol/albumin-bound linoleic acid lowered their proliferation rate and
altered cell morphology. SMCs expressed 2-10 times more mRNA for the core
proteins of the proteoglycans versican, decorin, and syndecan 4 compared
with control cells. There was no change in expression of fibronectin and
perlecan. The decorin glycosaminoglycan chains increased in size after
exposure to linoleic acid. The ECM produced by cells grown in the presence
of linoleic acid bound 125I-labeled LDL more tightly than that of control
cells. Darglitazone, a peroxisome proliferator-activated receptor
(PPAR)-gamma ligand, neutralized the NEFA-mediated induction of the decorin
gene. This suggests that some of the NEFA effects are mediated by
PPAR-gamma. These actions of NEFAs, if present in vivo, could contribute to
changes of the matrix of the arterial intima associated with micro- and
macroangiopathies.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. Tabas, K. J. Williams, and J. Boren
Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis: Update and Therapeutic Implications
Circulation,
October 16, 2007;
116(16):
1832 - 1844.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rodriguez-Lee, G. Ostergren-Lunden, B. Wallin, J. Moses, G. Bondjers, and G. Camejo
Fatty Acids Cause Alterations of Human Arterial Smooth Muscle Cell Proteoglycans That Increase the Affinity for Low-Density Lipoprotein
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2006;
26(1):
130 - 135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sun, I. M. Berquin, and I. J. Edwards
Omega-3 Polyunsaturated Fatty Acids Regulate Syndecan-1 Expression in Human Breast Cancer Cells
Cancer Res.,
May 15, 2005;
65(10):
4442 - 4447.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hashimura, K. Sudhir, J. Nigro, S. Ling, M. R. I. Williams, P. A. Komesaroff, and P. J. Little
Androgens Stimulate Human Vascular Smooth Muscle Cell Proteoglycan Biosynthesis and Increase Lipoprotein Binding
Endocrinology,
April 1, 2005;
146(4):
2085 - 2090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. H. Huang, D. Gu, and T. Mazzone
Oleic Acid Modulates the Post-translational Glycosylation of Macrophage ApoE to Increase Its Secretion
J. Biol. Chem.,
July 9, 2004;
279(28):
29195 - 29201.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. R. Mulvihill, J. Jaeger, R. Sengupta, W. L. Ruzzo, C. Reimer, S. Lukito, and S. M. Schwartz
Atherosclerotic Plaque Smooth Muscle Cells Have a Distinct Phenotype
Arterioscler. Thromb. Vasc. Biol.,
July 1, 2004;
24(7):
1283 - 1289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. N. Wight and M. J. Merrilees
Proteoglycans in Atherosclerosis and Restenosis: Key Roles for Versican
Circ. Res.,
May 14, 2004;
94(9):
1158 - 1167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Worley, M. D. Baugh, D. A. Hughes, D. R. Edwards, A. Hogan, M. J. Sampson, and J. Gavrilovic
Metalloproteinase Expression in PMA-stimulated THP-1 Cells: EFFECTS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-{gamma} (PPAR{gamma}) AGONISTS AND 9-CIS-RETINOIC ACID
J. Biol. Chem.,
December 19, 2003;
278(51):
51340 - 51346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Meyers, L. R. Tannock, T. N. Wight, and A. Chait
Statin-exposed vascular smooth muscle cells secrete proteoglycans with decreased binding affinity for LDL
J. Lipid Res.,
November 1, 2003;
44(11):
2152 - 2160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. O. Pentikainen, R. Oksjoki, K. Oorni, and P. T. Kovanen
Lipoprotein Lipase in the Arterial Wall: Linking LDL to the Arterial Extracellular Matrix and Much More
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2002;
22(2):
211 - 217.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Li and E. L. Chaikof
Mechanical Stress Regulates Syndecan-4 Expression and Redistribution in Vascular Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2002;
22(1):
61 - 68.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Olsson, A.-C. Egnell, M. R. Lee, G. O. Lunden, M. Lorentzon, M. Salmivirta, G. Bondjers, and G. Camejo
Changes in Matrix Proteoglycans Induced by Insulin and Fatty Acids in Hepatic Cells May Contribute to Dyslipidemia of Insulin Resistance
Diabetes,
September 1, 2001;
50(9):
2126 - 2132.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Hurt-Camejo, G. Camejo, H. Peilot, K. Oorni, and P. Kovanen
Phospholipase A2 in Vascular Disease
Circ. Res.,
August 17, 2001;
89(4):
298 - 304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Carlsson, Y. Wessman, P. Almgren, and L. Groop
High Levels of Nonesterified Fatty Acids Are Associated With Increased Familial Risk of Cardiovascular Disease
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2000;
20(6):
1588 - 1594.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Diabetes Association.
|
|
| |
|